180 related articles for article (PubMed ID: 20651054)
21. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
22. An approach of selecting appropriate markers from the primary tumor to enable detection of circulating tumor cells in patients with non-small cell lung cancer.
Warawdekar UM; Sirajuddin MM; Pramesh CS; Mistry RC
J BUON; 2015; 20(3):782-90. PubMed ID: 26214631
[TBL] [Abstract][Full Text] [Related]
23. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
24. Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
Pailler E; Oulhen M; Billiot F; Galland A; Auger N; Faugeroux V; Laplace-Builhé C; Besse B; Loriot Y; Ngo-Camus M; Hemanda M; Lindsay CR; Soria JC; Vielh P; Farace F
BMC Cancer; 2016 Jul; 16():477. PubMed ID: 27417942
[TBL] [Abstract][Full Text] [Related]
25. Multitarget FISH and LOH analyses at chromosome 3p in non-small cell lung cancer and adjacent bronchial epithelium.
Woenckhaus M; Grepmeier U; Wild PJ; Merk J; Pfeifer M; Woenckhaus U; Stoelcker B; Blaszyk H; Hofstaedter F; Dietmaier W; Hartmann A
Am J Clin Pathol; 2005 May; 123(5):752-61. PubMed ID: 15981815
[TBL] [Abstract][Full Text] [Related]
26. Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients.
Arrieta O; Pineda B; Muñiz-Hernández S; Flores D; Ordóñez G; Borbolla-Escoboza JR; Orta D
Cancer Biomark; 2014; 14(4):215-23. PubMed ID: 24934364
[TBL] [Abstract][Full Text] [Related]
27. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.
Varella-Garcia M; Schulte AP; Wolf HJ; Feser WJ; Zeng C; Braudrick S; Yin X; Hirsch FR; Kennedy TC; Keith RL; Barón AE; Belinsky SA; Miller YE; Byers T; Franklin WA
Cancer Prev Res (Phila); 2010 Apr; 3(4):447-53. PubMed ID: 20332298
[TBL] [Abstract][Full Text] [Related]
28. A Lightweight and Robust Framework for Circulating Genetically Abnormal Cells (CACs) Identification Using 4-Color Fluorescence In Situ Hybridization (FISH) Image and Deep Refined Learning.
Xu X; Li C; Lan X; Fan X; Lv X; Ye X; Wu T
J Digit Imaging; 2023 Aug; 36(4):1687-1700. PubMed ID: 37231288
[TBL] [Abstract][Full Text] [Related]
29. Attenuated isolated 3' signal: A highly challenging therapy relevant ALK FISH pattern in NSCLC.
Smuk G; Pajor G; Szuhai K; Morreau H; Kocsmár I; Kocsmár É; Pajor L; Kajtár B; Sárosi V; Lotz G; Tornóczky T
Lung Cancer; 2020 May; 143():80-85. PubMed ID: 32272316
[TBL] [Abstract][Full Text] [Related]
30. An efficient fluorescence in situ hybridization (FISH)-based circulating genetically abnormal cells (CACs) identification method based on Multi-scale MobileNet-YOLO-V4.
Xu C; Zhang Y; Fan X; Lan X; Ye X; Wu T
Quant Imaging Med Surg; 2022 May; 12(5):2961-2976. PubMed ID: 35502367
[TBL] [Abstract][Full Text] [Related]
31. Parallel FISH and immunohistochemical studies of ALK status in 3244 non-small-cell lung cancers reveal major discordances.
Cabillic F; Gros A; Dugay F; Begueret H; Mesturoux L; Chiforeanu DC; Dufrenot L; Jauffret V; Dachary D; Corre R; Lespagnol A; Soler G; Dagher J; Catros V; Le Calve M; Merlio JP; Belaud-Rotureau MA
J Thorac Oncol; 2014 Mar; 9(3):295-306. PubMed ID: 24518086
[TBL] [Abstract][Full Text] [Related]
32. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
33. Single tube liquid biopsy for advanced non-small cell lung cancer.
de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
[TBL] [Abstract][Full Text] [Related]
35. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
[TBL] [Abstract][Full Text] [Related]
36. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.
Simone G; Mangia A; Malfettone A; Rubini V; Siciliano M; Di Benedetto A; Terrenato I; Novelli F; Mottolese M
J Exp Clin Cancer Res; 2010 Sep; 29(1):125. PubMed ID: 20843314
[TBL] [Abstract][Full Text] [Related]
37. The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells.
Kulasinghe A; Lim Y; Kapeleris J; Warkiani M; O'Byrne K; Punyadeera C
Cells; 2020 Jun; 9(6):. PubMed ID: 32549278
[TBL] [Abstract][Full Text] [Related]
38. Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cells.
Dhar M; Pao E; Renier C; Go DE; Che J; Montoya R; Conrad R; Matsumoto M; Heirich K; Triboulet M; Rao J; Jeffrey SS; Garon EB; Goldman J; Rao NP; Kulkarni R; Sollier-Christen E; Di Carlo D
Sci Rep; 2016 Oct; 6():35474. PubMed ID: 27739521
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
Dong J; Zhu D; Tang X; Lu D; Qiu X; Li B; Lin D; Li L; Liu J; Zhou Q
PLoS One; 2019; 14(7):e0220306. PubMed ID: 31348821
[TBL] [Abstract][Full Text] [Related]
40. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]